IFM Investors Pty Ltd grew its holdings in Colgate-Palmolive (NYSE:CL) by 52.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 87,774 shares of the company’s stock after acquiring an additional 30,019 shares during the quarter. IFM Investors Pty Ltd’s holdings in Colgate-Palmolive were worth $6,452,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Buckingham Capital Management Inc. increased its position in Colgate-Palmolive by 0.5% in the 1st quarter. Buckingham Capital Management Inc. now owns 34,514 shares of the company’s stock valued at $2,366,000 after acquiring an additional 183 shares in the last quarter. Deane Retirement Strategies Inc. increased its position in Colgate-Palmolive by 1.4% in the 2nd quarter. Deane Retirement Strategies Inc. now owns 30,431 shares of the company’s stock valued at $2,181,000 after acquiring an additional 420 shares in the last quarter. Swedbank increased its position in Colgate-Palmolive by 1.2% in the 2nd quarter. Swedbank now owns 2,202,863 shares of the company’s stock valued at $157,880,000 after acquiring an additional 26,800 shares in the last quarter. Rockland Trust Co. increased its position in Colgate-Palmolive by 2.6% in the 2nd quarter. Rockland Trust Co. now owns 150,674 shares of the company’s stock valued at $10,799,000 after acquiring an additional 3,764 shares in the last quarter. Finally, WINTON GROUP Ltd boosted its stake in shares of Colgate-Palmolive by 10.3% in the 2nd quarter. WINTON GROUP Ltd now owns 727,968 shares of the company’s stock valued at $52,173,000 after purchasing an additional 68,192 shares during the last quarter. 76.09% of the stock is owned by institutional investors.
CL stock traded up $0.85 during midday trading on Wednesday, reaching $66.81. 86,447 shares of the company were exchanged, compared to its average volume of 3,579,738. The business has a 50-day moving average price of $69.80 and a two-hundred day moving average price of $71.62. Colgate-Palmolive has a one year low of $57.51 and a one year high of $76.41. The firm has a market capitalization of $57.32 billion, a price-to-earnings ratio of 22.48, a price-to-earnings-growth ratio of 4.40 and a beta of 0.73.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Wednesday, October 23rd will be given a dividend of $0.43 per share. The ex-dividend date of this dividend is Tuesday, October 22nd. This represents a $1.72 annualized dividend and a yield of 2.57%. Colgate-Palmolive’s dividend payout ratio is 57.91%.
Several research analysts have recently issued reports on the stock. Bank of America reduced their target price on shares of Colgate-Palmolive from $82.00 to $77.00 and set a “buy” rating on the stock in a research note on Monday. Deutsche Bank raised their target price on shares of Colgate-Palmolive from $74.00 to $76.00 and gave the company a “hold” rating in a research note on Friday, July 12th. Berenberg Bank assumed coverage on shares of Colgate-Palmolive in a research note on Wednesday, October 16th. They issued a “sell” rating and a $58.00 target price on the stock. JPMorgan Chase & Co. reduced their target price on shares of Colgate-Palmolive from $76.00 to $71.00 and set a “neutral” rating on the stock in a research note on Monday. Finally, UBS Group reduced their target price on shares of Colgate-Palmolive from $82.00 to $80.00 and set a “buy” rating on the stock in a research note on Tuesday. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the company. The company has an average rating of “Hold” and an average price target of $72.57.
In other Colgate-Palmolive news, CFO Henning I. Jakobsen sold 858 shares of the business’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $74.60, for a total transaction of $64,006.80. Following the completion of the transaction, the chief financial officer now owns 39,031 shares of the company’s stock, valued at $2,911,712.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Prabha Parameswaran sold 55,835 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $70.68, for a total value of $3,946,417.80. Following the transaction, the insider now directly owns 54,758 shares of the company’s stock, valued at approximately $3,870,295.44. The disclosure for this sale can be found here. Insiders have sold 257,196 shares of company stock valued at $18,239,955 in the last ninety days. 1.14% of the stock is currently owned by company insiders.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.